Sign inJoin waitlistJoin the waitlist

Katherine Scilla

Associate Program Director of the Hematology Medical Oncology Fellowship Program · Univ of Maryland Sch of Med

Credentials: · · · · ·

History

Hematology Medical Oncology Fellowship · Univ of Maryland Sch of Med
Present
University of Maryland Capital Region Health
Present
Univ of Maryland Sch of Med · University of Maryland Capital Region Health
Present

Hematology and Medical Oncology
University of Maryland Medical Center
2014–2017
Internal Medicine
University of Maryland Medical Center
2011–2014
State University of New York Upstate Medical University
2006–2010

Research

RET fusions in solid tumors
Review · Cancer Treatment Reviews · 2019 · 205 citations
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy
The Oncologist · 2017 · First of 10 authors · 94 citations
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)
Lung Cancer · 2017 · 76 citations

Christian Rolfo
14 papers
Ranee Mehra
11 papers
Michael McCusker
7 papers · 6 as a fellow
Pranshu Mohindra
5 papers · 1 as a resident
JF
Josephine Feliciano
4 papers
Martin Edelman
4 papers
Melissa Vyfhuis
4 papers · 4 as a resident
Ashutosh Sachdeva
3 papers
NB
Neha Bhooshan
3 papers · 2 as a resident
Steven Feigenberg
3 papers
Allison Gittens
2 papers
CS
Charles Simone
2 papers

Clinical trials

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
PrECOG, LLC.
2026–2030
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Site PI · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2025–2030
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 2
Georgetown University
2020–2027